TY - JOUR
T1 - Diagnosis of Duchenne Muscular Dystrophy in Italy in the last decade: Critical issues and areas for improvements
AU - D'Amico, Adele
AU - Catteruccia, Michela
AU - Baranello, Giovanni
AU - Politano, Luisa
AU - Govoni, Alessandra
AU - Previtali, Stefano Carlo
AU - Pane, Marika
AU - D'Angelo, Maria Grazia
AU - D'Angelo Bozzi, Michele Giovanni
AU - Bruno, Claudio
AU - Messina, Sonia
AU - Ricci, Federica
AU - Pegoraro, Elena
AU - Pini, Antonella
AU - Berardinelli, Angela
AU - Gorni, Ksenjia
AU - Battini, Roberta
AU - Vita, Gianluca
AU - Trucco, Federica
AU - Scutifero, Marianna
AU - Petillo, Roberta
AU - D'Ambrosio, Paola
AU - Ardissone, Anna
AU - Pasanisi, Barbara
AU - Vita, Giuseppe
AU - Mongini, Tiziana
AU - Moggio, Maurizio
AU - Comi, Giacomo Pietro
AU - Mercuri, Eugenio Maria
AU - Bertini, Enrico Silvio
PY - 2017
Y1 - 2017
N2 - Despite all the advances in diagnosis and management of Duchenne muscular dystrophy over the past 50 years, the average age at diagnosis in most countries in the world around is still around 4–5 years. This retrospective study investigates the age at diagnosis in Italy in the past 10 years. We report findings from 384 boys who were diagnosed with DMD from 2005 to 2014. The mean age at first medical contact, which raised the suspicion of DMD, was 31 months. The mean age at diagnosis was 41 months. The finding that more frequently brought to suspect a DMD was the incidental finding of consistent elevated creatine kinase serum level detected during routine assessments in children undergoing general anesthesia or with intercurrent illness. This was followed by motor delay and signs of muscle weakness. Initial concerns were raised by general pediatricians (29%), specialists at tertiary centers (35%) or first level hospitals (23%). In children presenting incidental elevated creatine kinase values the diagnosis was achieved earlier than in children presenting a developmental delay. The mean age at diagnosis in our cohort was about 10–12 months lower than that reported in other countries.
AB - Despite all the advances in diagnosis and management of Duchenne muscular dystrophy over the past 50 years, the average age at diagnosis in most countries in the world around is still around 4–5 years. This retrospective study investigates the age at diagnosis in Italy in the past 10 years. We report findings from 384 boys who were diagnosed with DMD from 2005 to 2014. The mean age at first medical contact, which raised the suspicion of DMD, was 31 months. The mean age at diagnosis was 41 months. The finding that more frequently brought to suspect a DMD was the incidental finding of consistent elevated creatine kinase serum level detected during routine assessments in children undergoing general anesthesia or with intercurrent illness. This was followed by motor delay and signs of muscle weakness. Initial concerns were raised by general pediatricians (29%), specialists at tertiary centers (35%) or first level hospitals (23%). In children presenting incidental elevated creatine kinase values the diagnosis was achieved earlier than in children presenting a developmental delay. The mean age at diagnosis in our cohort was about 10–12 months lower than that reported in other countries.
KW - DMD
KW - DMD screening
KW - Delayed diagnosis
KW - Survey
KW - DMD
KW - DMD screening
KW - Delayed diagnosis
KW - Survey
UR - http://hdl.handle.net/10807/260274
U2 - 10.1016/j.nmd.2017.02.006
DO - 10.1016/j.nmd.2017.02.006
M3 - Article
SN - 0960-8966
VL - 27
SP - 447
EP - 451
JO - Neuromuscular Disorders
JF - Neuromuscular Disorders
ER -